Effekt of nerandomilast on clinical outcomes in patients with progressive pulmonary fibrosis (PPF): results from the final database lock of the FIBRONEER-ILD trial*

M S Wijsenbeek, S Assassi, A Azuma, V Cottin, A-M Hoffmann-Vold, T Maher, F Martinez, J M Oldham, L Richeldi, C Valenzuela, H Gu, I Ritter, S Stowasser, M Kreuter · Pneumologie · 2026 · Heft S 01 S 01 · S. S165-S166